Correspondingly, LINE-1 methylation levels were significantly lower in tumors assigned to the methylation class “astrocytoma, IDH-mutant, high-grade” (Fig. S5a). This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).